Parkinson’s is a progressive neurological disorder related to a loss of nerve cells in a specific part of the brain. These nerve cells are responsible for producing a chemical called dopamine. When there is not enough dopamine in the body, it becomes difficult to control movements and move smoothly.
Symptoms differ from one person to the next and some of the more well-known or common outward symptoms include shaking or trembling, slowness of movement, and stiffness. However, there may be many other less obvious symptoms affecting quality of life, such as pain, depression, memory problems, sleep problems, difficulty swallowing, speech problems, bladder/bowel problems, and fatigue.
References: Parkinson’s UK website. Available at http://www.parkinsons.org.uk/content/what-parkinsons Parkinson’s Disease Foundation website. Available at http://www.pdf.org/en/about_pd NHS Choices website. Available at
Every hour, someone in the UK is told they have Parkinson’s disease. It is estimated that around 130,000 people in the UK are living with Parkinson’s disease, and more than 10 million people are affected worldwide.
Parkinson’s is more common in older people (>75 years) but can also affect younger people (< 50 years), and it tends to occur more often in men than in women.
Parkinson’s can usually be well controlled using a combination of drugs and other therapies, but as the condition progresses, treatment needs to be adapted and an increased amount of care and support may be required.
There are also several Parkinson’s websites and patient charities who can help with support and information for people with Parkinson’s and their carers, such as Parkinson’s UK (www.parkinsons.org.uk )
Parkinson’s UK website. Available at http://www.parkinsons.org.uk/content/what-parkinsons
Parkinson’s Disease Foundation website. Available at http://www.pdf.org/en/about_pd
Age UK website. Available at http://www.ageuk.org.uk/health-wellbeing/conditions-illnesses/parkinsons-disease/
Over the last 20 years, Ethypharm has gained real expertise in the design, development, registration, and manufacture of complex generic medicines, including prolonged release formulations. Ethypharm currently markets 20 brands of medicines directly or via partners in 30 countries, including two Parkinson’s medicines in the UK. Ethypharm UK is committed to providing high quality sustained release medicines with significant cost savings to the NHS.
If you have been prescribed an Ethypharm Parkinson’s medication, more information is coming soon regarding the patient information leaflets for Ipinnia ® XL (ropinirole prolonged-release tablets) and Pipexus (pramipexole prolonged release tablets). If you have any questions about your Ethypharm Parkinson’s medication, please contact your healthcare provider, or Ethypharm UK medical information on +44(0) 1483 662805 or email@example.com (please note that we are not able to provide medical advice).
Pain can be described as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage”, in other words, an uncomfortable feeling and/or unpleasant sensation that may or may not be related to an injury.
Pain can begin suddenly or come about slowly over time and can be classified as acute or chronic. Acute (short-term) pain is usually caused by a specific disease or injury and may last from moments to weeks or even months. Treatment of acute pain is aimed at treating the underlying injury and interrupting the pain signals to the brain. Chronic (long-term) pain may be regarded as a disease state in itself, the cause may not be known or well understood, and it sometimes results in pain-related disabilities.
Pain is always subjective. For this reason, the experience of pain and therefore its management, is unique to every individual.
It is estimated that 14 million people in the UK live with chronic pain. There are a number of treatment approaches and medicines that can be employed to help with the management of pain, which vary according to the specific diagnosis.
There are also several pain management societies, associations and patient charities who can help with support and information for people in pain and their carers, such as the British Pain Society’s “Understanding and managing long-term pain – information for people in pain”.
Pain UK. Available at https://painuk.org
British Pain Society. Available at https://www.britishpainsociety.org/people-with-pain/
Faculty of Pain Medicine: Core standards for pain management services in the UK (October 2015). Available at http://www.rcoa.ac.uk/system/files/FPM-CSPMS-UK2015.pdf
Over the last 20 years, Ethypharm has gained real expertise in the design, development, registration, and manufacture of pain medicines. Ethypharm currently markets 20 brands of pain medicines directly or via partners in 30 countries.
Ethypharm UK is committed to providing high quality sustained release medicines with significant cost savings to the NHS. We also encourage appropriate use of opioid medicines in pain management, as outlined in Public Health England’s “Opioids Aware” resource.
If you have been prescribed an Ethypharm pain medication, you can view the patient information leaflets for Abtard (oxycodone prolonged-release tablets) and Fencino (fentanyl transdermal patch). If you have any questions about your Ethypharm pain medication, please contact your healthcare provider, or Ethypharm UK medical information on 01483 662805 (please note that we are not able to provide medical advice).
Public Health England: Opioids Aware – a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain. Available at http://www.rcoa.ac.uk/faculty-of-pain-medicine/opioids-aware
Please feel free to contact us for any further question.
We are unable provide medical advice.
Reporting forms and information
can be found at:
Adverse events should also be reported to Ethypharm UK Ltd
Healthcare professionals medical information
Any personal data you share with us will remain confidential at all times.
Medical enquiries can be directed to the Medical Information department using the form below: